Effect of B-cell depletion on coreceptor switching in R5 simian-human immunodeficiency virus infection of rhesus macaques.
We recently described a coreceptor switch in rapid progressor (RP) R5 simian-human immunodeficiency virus SF162P3N (SHIV(SF162P3N))-infected rhesus macaques that had high virus replication and undetectable or weak and transient antiviral antibody response (S. H. Ho et al., J. Virol. 81:8621-8633, 2007; S. H. Ho, N. Trunova, A. Gettie, J. Blanchard, and C. Cheng-Mayer, J. Virol. 82:5653-5656, 2008; and W. Ren et al., J. Virol. 84:340-351, 2010). The lack of antibody selective pressure, together with the observation that the emerging X4 variants were neutralization sensitive, suggested that the absence or weakening of the virus-specific humoral immune response could be an environmental factor fostering coreceptor switching in vivo. To test this possibility, we treated four macaques with 50 mg/kg of body weight of the anti-CD20 antibody rituximab every 2 to 3 weeks starting from the week prior to intravenous infection with SHIV(SF162P3N) for a total of six infusions. Rituximab treatment successfully depleted peripheral and lymphoid CD20(+) cells for up to 25 weeks according to flow cytometry and immunohistochemical staining, with partial to full recovery in two of the four treated monkeys thereafter. Three of the four treated macaques failed to mount a detectable anti-SHIV antibody response, while the response was delayed in the remaining animal. The three seronegative macaques progressed to disease, but in none of them could the presence of X4 variants be demonstrated by V3 sequence and tropism analyses. Furthermore, viruses did not evolve early in these diseased macaques to be more soluble CD4 sensitive. These results demonstrate that the absence or diminution of humoral immune responses by itself is insufficient to drive the R5-to-X4 switch and the neutralization susceptibility of the evolving viruses.
Aaron Diamond AIDS Research Center, 455 First Avenue, 7th Floor, New York, NY 10016, USA.
Silvana
S
Tasca
Ke
K
Zhuang
Agegnehu
A
Gettie
Heather
H
Knight
James
J
Blanchard
Susan
S
Westmoreland
Cecilia
C
Cheng-Mayer
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D006678:HIV / Q000235:genetics / Q000472:pathogenicity*; D006801:Humans; D008212:Lymphocyte Depletion; D008253:Macaca mulatta; D011991:Receptors, Virus / Q000378:metabolism*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000472:pathogenicity*; D056189:Viral Tropism
D011991:Receptors, Virus
J Virol. 2000 Dec;74(23):11008-16
11069996
Ann Intern Med. 1993 May 1;118(9):681-8
8096374
J Virol. 2008 Jun;82(11):5653-6
18385246
Nat Rev Immunol. 2010 Apr;10(4):236-47
20224569
Clin Infect Dis. 2007 Sep 1;45(5):643-9
17683002
J Virol. 2009 Oct;83(20):10347-57
19656874
J Exp Med. 1997 Feb 17;185(4):621-8
9034141
AIDS. 1995;9 Suppl A:S117-36
8819579
Trends Microbiol. 2005 Jun;13(6):269-77
15936659
Science. 1991 Jul 5;253(5015):71-4
1905842
Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7
6096719
Curr Opin Immunol. 2008 Aug;20(4):444-9
18585457
AIDS Res Hum Retroviruses. 2004 Jan;20(1):111-26
15000703
J Virol. 1996 Dec;70(12):9055-9
8971043
J Virol. 2010 Jan;84(1):340-51
19846515
J Infect Dis. 2005 Mar 15;191(6):866-72
15717260
J Virol. 1992 May;66(5):3183-7
1560543
J Virol. 2008 Jul;82(14):7089-99
18480460
J Immunol. 2007 Sep 1;179(5):3351-61
17709552
J Virol. 2007 May;81(10):5024-35
17329327
Nature. 1998 Jun 18;393(6686):705-11
9641684
J Infect Dis. 1999 Jan;179(1):254-8
9841850
J Virol. 2007 Aug;81(16):8621-33
17537860
Annu Rev Immunol. 1999;17:657-700
10358771
J Virol. 1998 Dec;72(12):10108-17
9811751
J Virol. 2008 Aug;82(16):7932-41
18524815
Methods. 1997 Aug;12(4):348-54
9245616
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1269-74
10655520
Science. 1995 Jan 27;267(5197):483-9
7824947
Nat Med. 1996 Nov;2(11):1244-7
8898753
Nature. 2003 Mar 20;422(6929):307-12
12646921
Nat Med. 1997 Nov;3(11):1259-65
9359702
Nature. 1996 Jun 20;381(6584):661-6
8649511
J Virol. 1997 Dec;71(12):9808-12
9371651
J Virol. 1994 Sep;68(9):6006-13
8057475
Nat Med. 2008 Jun;14(6):623-8
18535580
J Virol. 1992 Nov;66(11):6777-80
1404617
J Cell Biol. 2000 Oct 16;151(2):F9-14
11038194
Nat Rev Immunol. 2008 Aug;8(8):619-30
18617886
Nature. 1991 Jan 10;349(6305):167-9
1986308
Annu Rev Immunol. 2006;24:739-69
16551265
Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9434-8
1409653
J Immunol. 2005 Jan 15;174(2):817-26
15634903
Virology. 2002 Dec 5;304(1):70-80
12490404
J Virol. 2003 Feb;77(3):2165-73
12525651
J Virol. 2005 Dec;79(23):14887-98
16282488